Log in to search using one of your social media accounts:

 

Arthritis warning: THIS common medication could be linked to deadly liver failure
ARTHRITIS causes symptoms including painful joints and stiffness. One type, rheumatoid arthritis, is often treated with medications that reduce discomfort - but the side effects of the drug methotrexate, can include liver failure. (Source: Daily Express - Health)
Source: Daily Express - Health - August 10, 2017 Category: Consumer Health News Source Type: news

Certain occupations linked to an increased risk of rheumatoid arthritis
(Wiley) New research indicates that certain occupations may put workers at an elevated risk of developing rheumatoid arthritis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 10, 2017 Category: International Medicine & Public Health Source Type: news

Certain occupations linked to increased risk of rheumatoid arthritis
Male manufacturing workers, bricklayers and concrete workers are at particularly high risk Related items fromOnMedica Fibre-rich diet linked to lowered risk of painful knee osteoarthritis Fibre-rich diet linked to lowered risk of painful knee osteoarthritis Chondroitin sulfate as good as widely used anti-inflammatory for knee osteoarthritis Rheumatoid arthritis Obesity may skew results of rheumatoid arthritis blood tests in women (Source: OnMedica Latest News)
Source: OnMedica Latest News - August 10, 2017 Category: UK Health Source Type: news

Rheumatoid arthritis - symptoms will not improve if patients do THIS
RHEUMATOID arthritis is a serious and disabling autoimmune disease in which the immune system mistakenly attacks and destroys healthy body tissue. (Source: Daily Express - Health)
Source: Daily Express - Health - August 9, 2017 Category: Consumer Health News Source Type: news

Finger prick test allows patients taking autoimmune drug to avoid blood draws
(Wiley) A new study shows that patients with rheumatoid arthritis and other autoimmune conditions who take the drug adalimumab can monitor drug levels in their bodies with a finger prick rather than undergoing a full blood draw. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 9, 2017 Category: International Medicine & Public Health Source Type: news

Insights tying bone cells to rheumatoid arthritis
An EU-funded project has generated new insights into the causes and development of rheumatoid arthritis, directing efforts towards earlier detection, prevention and the idea of inducing tolerance to this chronic and debilitating disease. Follow-up reearch includes new studies to further explore this 'tolerance' challenge and progress on a new antibody detecting device. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - August 7, 2017 Category: Research Source Type: news

Sirukumab Not Recommended for RA on Mortality Concerns Sirukumab Not Recommended for RA on Mortality Concerns
An FDA panel voted not to recommend sirukumab for adults with moderate-to-severe rheumatoid arthritis because of increased mortality in patients who took the drug in clinical trials.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 2, 2017 Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news

Fda advisory committee does not recommend approval of sirukumab for the treatment of moderately to severely active rheumatoid arthritis
(Source: Johnson and Johnson)
Source: Johnson and Johnson - August 2, 2017 Category: Pharmaceuticals Source Type: news

FDA panel votes against approval of J & J arthritis drug
(Reuters) - The benefits of Johnson& Johnson's experimental rheumatoid arthritis drug sirukumab do not outweigh the risks and it should not be approved, an advisory panel to the U.S. Food and Drug Administration concluded on Wednesday. (Source: Reuters: Health)
Source: Reuters: Health - August 2, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

FDA Advisory Committee Does Not Recommend Approval of Sirukumab for the Treatment of Moderately to Severely Active Rheumatoid Arthritis
HORSHAM, Pa., Aug. 2, 2017 /PRNewswire/ -- Janssen Biotech, Inc. announced today that the Arthritis Advisory Committee of the U.S. Food and Drug Administration (FDA) did not recommend approval of sirukumab (proposed trade name PLIVENSIA ™) for the... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - August 2, 2017 Category: Drugs & Pharmacology Source Type: news

Solomon Awarded FNIH Grant to Study Rheumatoid Arthritis Biomarkers
Daniel Solomon, MD, MPH, of the Division of Rheumatology, received a four-year, $850,000 grant from the Foundation for the National Institutes of Health (FNIH) to support his research that contributes to the FNIH TARGET Biomarker study. (Source: BWH News)
Source: BWH News - August 2, 2017 Category: Hospital Management Source Type: news

J & J Arthritis Drug Sirukumab Raises Safety Concerns -FDA Staff J & J Arthritis Drug Sirukumab Raises Safety Concerns -FDA Staff
There were more deaths in patients taking Johnson and Johnson's experimental rheumatoid arthritis drug sirukumab than among those taking a placebo, staff reviewers for the U.S. Food and Drug Administration said in a report published Monday.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - August 1, 2017 Category: Allergy & Immunology Tags: Pharmacist News Source Type: news

Pfizer revenue misses on lower Prevnar, Enbrel sales
(Reuters) - Pfizer Inc reported quarterly revenue on Tuesday that missed Wall Street estimates, driven by lower demand for its rheumatoid arthritis treatment Enbrel and pneumonia vaccine Prevnar. (Source: Reuters: Health)
Source: Reuters: Health - August 1, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Pfizer quarterly revenue slips 2 percent
(Reuters) - Pfizer Inc reported a nearly 2 percent drop in quarterly revenue on Tuesday, driven by lower demand for its rheumatoid arthritis treatment Enbrel and pneumonia vaccine Prevnar. (Source: Reuters: Health)
Source: Reuters: Health - August 1, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

J & J arthritis drug sirukumab raises safety concerns: FDA staff
(Reuters) - Staff reviewers for the U.S. Food and Drug Administration noted on Monday that there was a trend of increased death with Johnson& Johnson's experimental rheumatoid arthritis drug sirukumab compared with placebo. (Source: Reuters: Health)
Source: Reuters: Health - July 31, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Medical News Today: Gold injections: Can they treat rheumatoid arthritis?
What are gold injections and can they be used to treat rheumatoid arthritis? How are gold treatments administered and what may the side effects be? (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 31, 2017 Category: Consumer Health News Tags: Arthritis / Rheumatology Source Type: news

Immune system warning: These five conditions are because of inflammation
IMMUNE systems are designed to protect us, but sometimes the inflammation they trigger to fight off foreign substances goes wrong - and we ’re left with asthma, rheumatoid arthritis and a number of other conditions. (Source: Daily Express - Health)
Source: Daily Express - Health - July 30, 2017 Category: Consumer Health News Source Type: news

AbbVie's profit beats on Humira, Imbruvica demand
(Reuters) - U.S. drugmaker AbbVie Inc reported quarterly earnings on Friday that edged past analysts' expectations, helped by robust demand for its flagship rheumatoid arthritis drug, Humira. (Source: Reuters: Health)
Source: Reuters: Health - July 28, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

AbbVie's profit beats on robust Humira demand
(Reuters) - U.S. drugmaker AbbVie Inc reported quarterly earnings on Friday that edged past analysts' expectations, helped by robust demand for its flagship rheumatoid arthritis drug, Humira. (Source: Reuters: Health)
Source: Reuters: Health - July 28, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

AbbVie's profit rises 19 percent on Humira demand
(Reuters) - U.S. drugmaker AbbVie Inc reported an 18.9 percent rise in quarterly profit on Friday on strong demand for its flagship rheumatoid arthritis drug, Humira. (Source: Reuters: Health)
Source: Reuters: Health - July 28, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Arthritis symptoms: Would YOU be able to spot these five RARE types?
ARTHRITIS is a disease causing inflammation and stiffness in the joints. Despite their prevalence, osteoarthritis and rheumatoid arthritis are not the only types - would you be able to spot the symptoms of these rarer forms? (Source: Daily Express - Health)
Source: Daily Express - Health - July 26, 2017 Category: Consumer Health News Source Type: news

Lilly signals long delay for arthritis drug, shares fall
(Reuters) - Eli Lilly and Co on Tuesday outlined a likely multi-year delay for its experimental rheumatoid arthritis drug with blockbuster sales potential, and disappointed investors sent its shares down nearly 4 percent. (Source: Reuters: Health)
Source: Reuters: Health - July 25, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Merck, Samsung Bioepis launch discounted U.S. Remicade alternative
NEW YORK/SEOUL (Reuters) - Merck& Co and South Korea's Samsung Bioepis Co Ltd said on Monday they have begun selling a less expensive alternative version of Johnson& Johnson's rheumatoid arthritis drug Remicade in the United States, a move that should accelerate price declines for the big-selling medicine. (Source: Reuters: Health)
Source: Reuters: Health - July 24, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Merck launches biosimilar version of J & J blockbuster Remicade
Merck and Co. Inc. on Monday became the second pharmaceutical company to launch a biosimilar version of Remicade, a drug that generates billions of dollars a year in sales for Johnson& Johnson. Renflexis, the Merck biosimilar product, was approved by the Food and Drug Administration on April 21 as a treatment for rheumatoid arthritis, Crohn's disease, ulcerative colitis and ankylosing spondylitis. It is the first medicine available in the United States under a global biosimilars develop ment and… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - July 24, 2017 Category: Health Management Authors: John George Source Type: news

Samsung Bioepis launches U.S. sales of Remicade biosmiliar
SEOUL (Reuters) - South Korea's Samsung Bioepis Co Ltd said it started U.S sales of its copy of Johnson& Johnson's rheumatoid arthritis drug Remicade on Monday - a move set to further undermine sales of the U.S. firm's top-selling drug. (Source: Reuters: Health)
Source: Reuters: Health - July 24, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

New video: Patient and researcher fight JRA together
Have you ever heard ofjuvenile rheumatoid arthritis (JRA)? A lot of people haven ’t. (Source: The Catalyst)
Source: The Catalyst - July 19, 2017 Category: Pharmaceuticals Source Type: news

Cardiovascular Imaging in the Assessment of CV Risk in RA Cardiovascular Imaging in the Assessment of CV Risk in RA
Find out which imaging techniques may play a role in the cardiovascular risk stratification of patients with rheumatoid arthritis.Annals of the Rheumatic Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 19, 2017 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Singapore scientists pave way for better juvenile arthritis diagnosis & treatment outcome prediction
(SingHealth) They discovered a previously unknown group of regulatory T cells linked to the disease and DNA features that affect patients' response to treatment.Findings pave the way for improved juvenile arthritis diagnosis and prediction of treatment outcomes, and are also relevant for adult rheumatoid arthritis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 13, 2017 Category: International Medicine & Public Health Source Type: news

Arthritis treatment - are you worred about THESE side effects of drugs?
RHEUMATOID arthritis is a condition which can be treated with painkillers or non steroidal anti inflammatories. (Source: Daily Express - Health)
Source: Daily Express - Health - July 11, 2017 Category: Consumer Health News Source Type: news

Rheumatoid Arthritis vs. Fibromyalgia
Title: Rheumatoid Arthritis vs. FibromyalgiaCategory: Diseases and ConditionsCreated: 7/5/2017 12:00:00 AMLast Editorial Review: 7/5/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - July 5, 2017 Category: Rheumatology Source Type: news

Lilly and Incyte receive marketing approval for RA treatment Olumiant in Japan
The Japanese Ministry of Health, Labour and Welfare (MHLW) has granted marketing approval for Olumiant (baricitinib) 2mg and 4mg tablets for the treatment of rheumatoid arthritis (RA). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - July 4, 2017 Category: Pharmaceuticals Source Type: news

Japan Ministry of Health, Labor and Welfare (MHLW) Grants Marketing Approval For Olumiant(R) (baricitinib) for the Treatment of Rheumatoid Arthritis
INDIANAPOLIS, July 3, 2017 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) announced today that Japan's Ministry of Health, Labor and Welfare (MHLW) granted marketing approval for Olumia... Biopharmaceuticals, Regulatory Eli Lilly, Olumiant, baricitinib, rheumatoid arthritis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 3, 2017 Category: Pharmaceuticals Source Type: news

Sarilumab (Kevzara) Approved in EU for Rheumatoid Arthritis Sarilumab (Kevzara) Approved in EU for Rheumatoid Arthritis
Sarilumab is indicated for adults with moderate to severe active rheumatoid arthritis who fail or are intolerant to disease-modifying antirheumatic drugs.International Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 3, 2017 Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news

Improving VNS therapy: ElectroCore CEO Amato on gammaCore and its slated July launch
Neuroscience tech developer ElectroCore said recently it plans to launch its handheld gammaCore vagus nerve stimulation device in the US in mid-July, after having won clearance from the FDA in April for treating episodic cluster headaches. Unlike other vagus nerve stimulation devices, the gammaCore is an external handheld device with no implanted component, designed to be used in a pain-free procedure, CEO Frank Amato told MassDevice.com in an interview. “Its a first-of-its-kind type of device,” Amato said, speaking on the recently approved and soon-to-launch gammaCore. “Vagus nerve stimulators have been ...
Source: Mass Device - June 30, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Neuromodulation/Neurostimulation Pain Management Source Type: news

Parkinson’s disease, arthritis or bowel disease: Can YOU afford to buy prescriptions?
PARKINSON ’S disease, rheumatoid arthritis and inflammatory bowel disease are all types of long-term conditions and sufferers often need constant medication and repeat prescriptions. (Source: Daily Express - Health)
Source: Daily Express - Health - June 28, 2017 Category: Consumer Health News Source Type: news

Rheumatoid arthritis: It boosts risk of painful condition sometimes triggered by GARDENING
RHEUMATOID arthritis can have a debilitating effect on the quality of life of sufferers - and, unfortunately, it ’s also a risk factor in another painful condition, tendonitis. (Source: Daily Express - Health)
Source: Daily Express - Health - June 27, 2017 Category: Consumer Health News Source Type: news

Novartis gets European OK for biosimilar of Amgen's Enbrel
ZURICH (Reuters) - Novartis's generics unit Sandoz said the European Commission approved Erelzi, its biosimilar to Amgen's Enbrel, to treat inflammatory diseases such as rheumatoid arthritis, psoriasis, and psoriatic arthritis. (Source: Reuters: Health)
Source: Reuters: Health - June 27, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Mount Sinai, Pfizer renew research collaboration, building on strong foundation
(The Mount Sinai Hospital / Mount Sinai School of Medicine) The Icahn School of Medicine at Mount Sinai and Pfizer Inc.'s Centers for Therapeutic Innovation (CTI) today announced the renewal of an agreement designed to identify and advance new drug candidates linked to major diseases, such as cancer, rheumatoid arthritis, Crohn's disease, colitis, heart failure, Alzheimer's disease, and cystic fibrosis. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 27, 2017 Category: Cancer & Oncology Source Type: news

Eating Fish May Ease Rheumatoid Arthritis (CME/CE)
(MedPage Today) -- Cross-sectional study ties fish with diminished disease activity (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - June 26, 2017 Category: American Health Source Type: news

Monotherapy With Biologic DMARDs in Rheumatoid Arthritis Monotherapy With Biologic DMARDs in Rheumatoid Arthritis
Biologic DMARD monotherapy may be a viable treatment alternative for patients with rheumatoid arthritis when combination therapy is not an option.Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 26, 2017 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Fish Eaters Find Less Rheumatoid Arthritis Pain
Study suggests most fish may play role in controlling symptoms (Source: WebMD Health)
Source: WebMD Health - June 23, 2017 Category: Consumer Health News Source Type: news

Eating fish may significantly reduce rheumatoid arthritis pain
Eating fish at least twice a week may significantly reduce the pain and swelling associated with rheumatoid arthritis, a new study says. (Source: Health News - UPI.com)
Source: Health News - UPI.com - June 23, 2017 Category: Consumer Health News Source Type: news

Fish Eaters Report Less Rheumatoid Arthritis Pain
Study suggests most fish may play role in controlling symptoms Source: HealthDay Related MedlinePlus Pages: Dietary Fats, Rheumatoid Arthritis (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - June 23, 2017 Category: Consumer Health News Source Type: news

Fish Eaters Report Less Rheumatoid Arthritis Pain
FRIDAY, June 23, 2017 -- Eating fish at least twice a week may significantly reduce the pain and swelling associated with rheumatoid arthritis, a new study says. Prior studies have shown a beneficial effect of fish oil supplements on rheumatoid... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 23, 2017 Category: General Medicine Source Type: news

EU backs second biosimilar copy of Humira, world's top drug
FRANKFURT (Reuters) - European regulators have recommended approval of a second copy of AbbVie's rheumatoid arthritis drug Humira, the world's top-selling medicine, in a further boost for so-called biosimilars in the region. (Source: Reuters: Health)
Source: Reuters: Health - June 23, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Eating Fish May Reduce Rheumatoid Arthritis Symptoms Eating Fish May Reduce Rheumatoid Arthritis Symptoms
Eating fish two or more times per week was associated with lower disease activity in a cross-sectional analysis of patients with rheumatoid arthritis.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 23, 2017 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Rheumatoid arthritis symptoms: Eating THIS twice a week may reduce joint pain
RHEUMATOID arthritis affects one per cent of the population, but new research has discovered how fish can help relieve painful symptoms. (Source: Daily Express - Health)
Source: Daily Express - Health - June 23, 2017 Category: Consumer Health News Source Type: news

Eating Fish May Reduce Rheumatoid Arthritis
Symptoms (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 23, 2017 Category: General Medicine Source Type: news

Eating more fish 'can alleviate rheumatoid arthritis symptoms'
This study indicates that simple changes, such as increasing the amount of fish in their diets, could have a big impact on making the condition more manageable. Lead author Dr Sara Tedeschi, of the division of rheumatology, immunology and allergy at Brigham and Women's Hospital and Harvard Medical School, said:"If our finding holds up in other studies, it suggests that fish consumption may lower inflammation related to rheumatoid arthritis disease activity. "Fish consumption has been noted to have many beneficial health effects, and our findings may give patients with rheumatoid arthritis a strong reason to i...
Source: Arthritis Research UK - June 21, 2017 Category: Rheumatology Source Type: news